Seventeen researchers at the Department of Oncology-Pathology (OnkPat) have been awarded a total of SEK 57.85 million in research grants in the Swedish Cancer Society's latest funding round. The projects span several areas of cancer research, including precision medicine, diagnostics and new treatment strategies.
Karolinska Institutet is the largest recipient in the Swedish Cancer Society's latest funding round. Researchers at 16 KI departments have been awarded approximately SEK 352 million across 98 grants. The funding round comprises more than SEK 916 million for Swedish cancer research, distributed across 247 grants at 13 Swedish higher education institutions.
At OnkPat, the following researchers have been awarded grants:
Project: Targeted Monitoring and Precision Therapy in Human Papillomavirus (HPV)-Driven Head and Neck Cancer
Grant awarded: SEK 4,500,000, 2027-2029.
Project: Artificial Intelligence and Genetics for Diagnosis and Prognosis of Prostate Cancer
Grant awarded: SEK 2,000,000, 2027-2028.
Project: Overcoming Resistance to Targeted Therapies in Lung Cancer - Novel Therapeutics using a Multiomics Approach
Grant awarded: SEK 3,000,000, 2027-2029.
Project: Genetic determinants of oncogenic transcriptional regulation in pediatric ALL by large-scale allelic footprinting and deep learning
Grant awarded: SEK 4,500,000, 2027-2029.
Project: Circadian oncogene gating: a noise-generating mechanism driving cancer evolution
Grant awarded: SEK 1,600,000, 2027-2028.
Project: From Dichotomy to Continuum: Advancing Estrogen Receptor Assessment for Breast Cancer Precision Oncology
Grant awarded: SEK 3,750,000, 2027-2029.
Project: AmotL2 isoform-dependent mechanonuclear coupling and epigenetic modulation in invasive cancer
Grant awarded: SEK 4,500,000, 2027-2029.
Project: Proteoform-guided precision therapy in acute lymphoblastic leukemia through integrative multi-omics
Grant awarded: SEK 3,000,000, 2027-2029.
Project: Deciphering Dedifferentiation and Radioiodine Resistance in Thyroid Cancer: Integrated Multi-Omics and Functional Approaches for Precision Oncology
Grant awarded: SEK 4,500,000, 2027-2029.
Project: Improving radioligand therapy response in neuroblastoma through rational radiosensitization
Grant awarded: SEK 3,000,000, 2027-2029.
Project: Molecular, clinical and functional aspects of endocrine tumor development - a precision medicine approach
Grant awarded: SEK 4,500,000, 2027-2029.
Project: Translating chromosomal aberrations into therapeutic targets through proteome network analysis of breast cancer
Grant awarded: SEK 6,000,000, 2027-2029.
Project: Definining viral oncoprotein-driven networks and CD44 regulation to reveal therapeutic vulnerabilities in Merkel cell carcinoma
Grant awarded: SEK 3,000,000, 2027-2029.
Project: Diagnostic and Prognostic Markers in Head and Neck Cancer: Focus on Oropharyngeal Squamous Cell Carcinoma (OPSCC), Oral Squamous Cell Carcinoma (OSCC) and Malignant Salivary Gland Tumors (MST).
Grant awarded: SEK 3,000,000, 2027-2029.
Project: Towards a mechanistic basis for precision antimetabolite therapy in cancer
Grant awarded: SEK 3,000,000, 2027-2029.
Project: Deconstructing and rebuilding tumours: AI and single-cell analysis for cancer biology and risk stratification
Grant awarded: SEK 3,000,000, 2027-2029.
Project: Accelerated Aging, Reproductive Aging and Biological Vulnerability in Childhood, Adolescence and Young Adulthood Cancer Survivors
Grant awarded: SEK 1,000,000, 2027.